» Articles » PMID: 16239320

Characterization of a Side Population of Cancer Cells from Human Gastrointestinal System

Overview
Journal Stem Cells
Date 2005 Oct 22
PMID 16239320
Citations 245
Authors
Affiliations
Soon will be listed here.
Abstract

A subset of stem cells, termed "side population" (SP) cells, has been identified and characterized in several mammalian tissues and cell lines. However, SP cells have never been identified or isolated from gastrointestinal cancers. We used flow cytometry and the DNA-binding dye Hoechst 33342 to isolate SP cells from various human gastrointestinal system cancer cell lines. Fifteen of sixteen cancer cell lines from the gastrointestinal system contained 0.3%-2.2% SP cells. Next, we used an oligonucleotide microarray to analyze differentially expressed genes between SP and non-SP cells of hepatoma HuH7. The expression of GATA6, which is associated with embryonic development and hepatocytic differentiation, was significantly upregulated in HuH7 SP cells. The expression of ABCG2, ABCB1, and CEACAM6, which are associated with chemoresistance, was also significantly increased in SP cells. In addition, some epithelial markers and mesenchymal markers were overexpressed in SP cells. Reverse transcription-polymerase chain reaction and immunocytochemical staining validated these results and suggested a multilineage potential for HuH7 SP cells. In hepatoma HuH7 and colorectal SW480 cell lines, SP cells showed evidence for self-renewal, generating both SP and non-SP cells. Finally, chemoresistance to anticancer agents, including doxorubicin, 5-fluorouracil, and gemcitabine, were compared between HuH7 SP and non-SP cells using an ATP bioluminescence assay. The HuH7 SP cells expressed a higher resistance to doxorubicin, 5-fluorouracil, and gemcitabine compared with non-SP cells. These findings demonstrate that cancers of the gastrointestinal system do contain SP cells that show some characteristics of so-called stem cells.

Citing Articles

Role of Cancer Side Population Stem Cells in Ovarian Cancer Angiogenesis.

Pan Y, Yang X, Chen M, Shi K, Lyu Y, Meeson A Med Princ Pract. 2024; 33(5):403-413.

PMID: 39068919 PMC: 11460956. DOI: 10.1159/000539642.


polysaccharide reverses drug resistance in oxaliplatin-resistant colon cancer cells by inhibiting PI3K/AKT-dependent phosphomannose isomerase.

Ma L, Ai F, Xiao H, Wang F, Shi L, Bai X Front Pharmacol. 2024; 15:1367747.

PMID: 38576495 PMC: 10991850. DOI: 10.3389/fphar.2024.1367747.


Therapeutic Strategies for Pancreatic-Cancer-Related Type 2 Diabetes Centered around Natural Products.

Park M Int J Mol Sci. 2023; 24(21).

PMID: 37958889 PMC: 10648679. DOI: 10.3390/ijms242115906.


Gene and ABCG2 Protein Expression in Colorectal Cancer-In Silico and Wet Analysis.

Salagacka-Kubiak A, Zawada D, Saed L, Kordek R, Jelen A, Balcerczak E Int J Mol Sci. 2023; 24(13).

PMID: 37445716 PMC: 10341438. DOI: 10.3390/ijms241310539.


MASM inhibits cancer stem cell-like characteristics of EpCAM cells via AKT/GSK3β/β-catenin signaling.

Sun K, Shen H, He S, Liu Y Am J Transl Res. 2022; 14(11):8380-8389.

PMID: 36505290 PMC: 9730073.